Lexaria Bioscience (LEXX) Exchange Rate Effect (2023 - 2026)
Lexaria Bioscience's (LEXX) quarterly Exchange Rate Effect came in at $20635.0 in Q1 2026, up 121.66% year-on-year from $9309.2 in Q1 2025, and up 459.24% quarter-over-quarter from -$5744.0 in Q4 2025.
Lexaria Bioscience (LEXX) Exchange Rate Effect (2023 - 2026) Analysis & Trends
Lexaria Bioscience has disclosed Exchange Rate Effect across 4 years of filings, most recently posting $20635.0 for Q1 2026.
- Exchange Rate Effect for Q1 2026 came in at $20635.0, up 121.66% year-over-year; the trailing twelve-month figure through Feb 2026 was $62802.0 (up 164.33% YoY), and the FY2025 annual result was -$50519.0, down 154.94% from the prior year.
- Exchange Rate Effect came in at $20635.0 for Q1 2026 at Lexaria Bioscience, up from -$5744.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $37173.0 in Q2 2025 to a low of -$95255.0 in Q1 2025.
- The 4-year median for Exchange Rate Effect is $405.0 (2024), against an average of -$5544.4.
- Peak annual rise in Exchange Rate Effect reached 3097.82% in 2025, while the deepest fall reached 281.05% in 2025.
- Lexaria Bioscience's Exchange Rate Effect stood at $4372.0 in 2023, then sank by 172.62% to -$3175.0 in 2024, then plunged by 80.91% to -$5744.0 in 2025, then soared by 459.24% to $20635.0 in 2026.
- The last three Exchange Rate Effect figures came in at $20635.0 (Q1 2026), -$5744.0 (Q4 2025), and $10738.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FX Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 8.68 Mn |
| 10 | Lexaria Bioscience | 7.17 Mn | 1.65 Mn | 20,000.00 | 20,635.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 20,635.00 |
| Feb 28, 2026 | 20,635.00 |
| Nov 30, 2025 | -5,744.00 |
| Nov 30, 2025 | -5,744.00 |
| Aug 31, 2025 | 10,738.00 |
| Aug 31, 2025 | 10,738.00 |
| May 31, 2025 | 37,173.00 |
| May 31, 2025 | 37,173.00 |
| Feb 28, 2025 | -95,255.00 |
| Feb 28, 2025 | -95,255.00 |
| Nov 30, 2024 | -3,175.00 |
| Nov 30, 2024 | -3,175.00 |
| Aug 31, 2024 | 2,050.00 |
| Aug 31, 2024 | 2,050.00 |
| May 31, 2024 | -1,240.00 |
| May 31, 2024 | -1,240.00 |
| Feb 29, 2024 | -24,998.00 |
| Feb 29, 2024 | -24,998.00 |
| Nov 30, 2023 | 4,372.00 |
| Nov 30, 2023 | 4,372.00 |